Catalyst Event
Eli Lilly and Co (LLY) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
5/12/2026, 12:00:00 AM
Eli Lilly announced positive late-stage trial results showing patients maintained long-term weight loss by switching from high-dose injectable GLP-1s to lower-dose Zepbound or the oral pill Foundayo (orforglipron).
Korean Translation
일라이 릴리, 고용량 주사형 GLP-1에서 저용량 제프바운드 또는 경구용 알약 파운다요(오르포글리프론)로 전환한 환자들이 장기적으로 체중 감소를 유지했다는 긍정적인 후기 임상시험 결과를 발표함.
Related Recent Events
ON Semiconductor Corp (ON) · Other
Financial Analyst Day 2026 is scheduled for 2026-09-16; this event is estimated to have a ≥1% price impact, scheduled.
9/16/2026, 12:00:00 AM
Roblox Corp (RBLX) · Earnings Release
Roblox is scheduled to release its Q2 2026 earnings report on 2026-08-11. Low importance is estimated as date announcements have minimal impact, scheduled
8/11/2026, 12:00:00 AM
Kratos Defense & Security Solutions Inc (KTOS) · Earnings Release
Next quarterly earnings report for Q2 2026 is scheduled. Market impact is estimated at Medium as earnings releases typically result in 5-10% price movement.
8/6/2026, 12:00:00 AM
Curtiss-Wright Corp (CW) · Earnings Release
Q2 2026 earnings release expected.
8/5/2026, 12:00:00 AM
Occidental Petroleum Corp (OXY) · Earnings Release
Occidental Petroleum is expected to report its Q2 2026 earnings results around August 5, 2026, based on historical patterns expected.
8/5/2026, 12:00:00 AM
Masco Corporation (MAS) · Earnings Release
Masco's Q2 2026 earnings release is scheduled for July 30, 2026. Estimated 5% impact based on historical volatility during earnings periods expected.
7/30/2026, 12:00:00 AM